- Home
- HIO vs CYRX Comparison
HIO vs CYRX Comparison
Compare HIO & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- CYRX
- Stock Information
- Founded
- HIO 1993
- CYRX 1999
- Country
- HIO United States
- CYRX United States
- Employees
- HIO N/A
- CYRX N/A
- Industry
- HIO Finance/Investors Services
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- CYRX Health Care
- Exchange
- HIO Nasdaq
- CYRX Nasdaq
- Market Cap
- HIO 368.0M
- CYRX 438.7M
- IPO Year
- HIO N/A
- CYRX N/A
- Fundamental
- Price
- HIO $3.72
- CYRX $8.80
- Analyst Decision
- HIO
- CYRX Strong Buy
- Analyst Count
- HIO 0
- CYRX 9
- Target Price
- HIO N/A
- CYRX $12.83
- AVG Volume (30 Days)
- HIO 305.3K
- CYRX 752.7K
- Earning Date
- HIO 01-01-0001
- CYRX 11-04-2025
- Dividend Yield
- HIO 10.33%
- CYRX N/A
- EPS Growth
- HIO N/A
- CYRX N/A
- EPS
- HIO N/A
- CYRX 1.27
- Revenue
- HIO N/A
- CYRX $243,795,000.00
- Revenue This Year
- HIO N/A
- CYRX N/A
- Revenue Next Year
- HIO N/A
- CYRX $9.20
- P/E Ratio
- HIO N/A
- CYRX $6.95
- Revenue Growth
- HIO N/A
- CYRX 41.27
- 52 Week Low
- HIO $3.52
- CYRX $4.58
- 52 Week High
- HIO $4.03
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- HIO 34.00
- CYRX 46.95
- Support Level
- HIO $3.75
- CYRX $8.15
- Resistance Level
- HIO $3.88
- CYRX $9.29
- Average True Range (ATR)
- HIO 0.03
- CYRX 0.49
- MACD
- HIO -0.01
- CYRX -0.02
- Stochastic Oscillator
- HIO 25.00
- CYRX 43.54
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.